Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00259-019-04328-1 | DOI Listing |
After standard treatment of glioblastoma, pseudoprogression versus true progression is a clinical challenge. Indeed, to differentiate these 2 on contrast MRI (cMRI) is problematic. In recent time, Ga-prostate-specific membrane antigen-11 (Ga-PSMA) PET/CT has been suggested to have high accuracy in glioblastoma recurrence.
View Article and Find Full Text PDFFront Oncol
November 2019
UNIV Lyon - Université Claude Bernard Lyon 1, LAGEPP UMR 5007 CNRS Villeurbanne, Villeurbanne, France.
Although rare, glioblastomas account for the majority of primary brain lesions, with a dreadful prognosis. Magnetic resonance imaging (MRI) is currently the imaging method providing the higher resolution. However, it does not always succeed in distinguishing recurrences from non-specific temozolomide, have been shown to improve -related changes caused by the combination of radiotherapy, chemotherapy, and targeted therapy, also called pseudoprogression.
View Article and Find Full Text PDFEur J Nucl Med Mol Imaging
July 2019
Department of Radiology, Hospital Sírio-Libanês, Rua Dona Adma Jafet 115, São Paulo, SP, CEP 01308-060, Brazil.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!